🇺🇸 FDA

Company profile · Sponsor

Sensei

Sensei Biotherapeutics

SNSE · NYSE pharma ROCKVILLE, MD, USA
Pipeline
3
Drugs
0
Patents
1

Quick answer

Sensei (SNSE) is a pharma company. headquartered in ROCKVILLE, MD, USA. listed on NYSE. NovaPharmaNews links 3 pipeline programs, 0 drugs, and 1 patent to this profile..

Company facts

Ticker SNSE
Exchange NYSE
Company type pharma
Headquarters ROCKVILLE, MD, USA
SEC CIK 0001829802

Pipeline (3)

Search pipeline →

  1. SNS-301

    Sensei

    Myelodysplastic Syndromes

    phase 2 small molecule terminated

    1 trial

  2. SNS-301

    Sensei

    Squamous Cell Carcinoma of the Head and Neck

    phase 2 small molecule terminated

    1 trial

  3. PAN-301-1

    Sensei

    Prostate Cancer

    phase 1 mab completed

    1 trial

Patents (1)

Search patents →

  1. US 11932695

    Modified antibodies and related compounds, compositions and methods of use

    Expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Sensei?

Sensei (SNSE) is a pharma company. headquartered in ROCKVILLE, MD, USA. listed on NYSE. NovaPharmaNews links 3 pipeline programs, 0 drugs, and 1 patent to this profile..

What pipeline programs does Sensei sponsor?

We track 3 ClinicalTrials.gov-linked programs for Sensei, including SNS-301 and 2 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Sensei company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.